Redox Biology · 2018 · 94 citations · 24 references
Life SciencesNeurosciencePharmacologyMolecular NeuroscienceNeurochemistryNeuropharmacologyAntioxidant DefenseNeuroprotectionOxidative Damage To BiomoleculesOxidative StressOxidative Stress In NeurotoxicityOxidative Stress MechanismsAntioxidant Defense MechanismsNrf2 Pathway ActivationNrf2 Signaling PathwayNrf2-mediated Cytoprotective SignalingNrf2-mediated ResponsesOxidative Stress - Induced NeurotoxicityOxidative Stress InjuryOxidative Stress Toxicity
Oxidative stress plays a key role in neurodegenerative diseases such as Alzheimer's and Parkinson's diseases. Therefore, the nuclear factor-E2-related factor 2 (Nrf2), a key regulator of the antioxidative response, is considered to be important as a therapeutic target for neurodegenerative diseases. We investigated the underlying mechanism of Nrf2-mediated neuroprotective effects against oxidative stress in the PC12 cell line by 7β-(3-ethyl-cis-crotonoyloxy)-1α-(2-methylbutyryloxy)-3,14-dehydro-Z-notonipetranone (ECN), one of the sesquiterpenoids in Farfarae Flos. Pretreatment of PC12 cells with ECN had a protective effect against hydrogen peroxide (H2O2)- or 6-hydroxydopamine (6-OHDA)-induced cytotoxicity. ECN upregulated the ARE-luciferase activity and induced the mRNA expression of Nrf2 and antioxidant enzyme heme oxygenase-1 (HO-1). Knockdown of Nrf2 by small, interfering RNA (siRNA) abrogated the upregulation of HO-1, indicating that ECN had induced HO-1 via the Nrf2 pathway. Pretreatment with the thiol reducing agents, N-acetylcysteine (NAC) or dithiothreitol (DTT), attenuated Nrf2 activation and HO-1 expression. However, the non-thiol reducing antioxidant, Trolox, failed to inhibit HO-1 induction by ECN. These results suggest that ECN may directly interact with Kelch-like ECH-associated protein 1 (Keap1) and modify critical cysteine thiols present in the proteins responsible for Nrf2-mediated upregulation of HO-1. In a 6-OHDA-induced mouse model of PD, administration of ECN ameliorated motor impairments and dopaminergic neuronal damage. Taken together, ECN exerts neuroprotective effects by activating the Nrf2/HO-1 signaling pathway in both PC12 cells and mice. Thus, ECN, as an Nrf2 activator, could be an attractive therapeutic candidate for the neuroprotection or treatment of neurodegenerative diseases.
24
Disease duration and the integrity of the nigrostriatal system in Parkinson’s disease
Jeffrey H. Kordower, C. Warren Olanow, Hemraj B. Dodiya et al. · Brain · 2013 · 1.3K citations · Full text
Role of Oxidative Stress in Parkinson's Disease
Onyou Hwang · Experimental Neurobiology · 2013 · 836 citations · Full text
Daniel Martı́n, Ana I. Rojo, Marta Salinas et al. · Journal of Biological Chemistry · 2004 · 700 citations · Full text